Precision Biosciences Inc
DTIL· Nasdaq
DTILPrecision Biosciences Inc
Filed Mar 10, 2020 · 10-K · 70 days after period end · 0001564590-20-009541
derived · Computed from the longer spans the company filed.
| Metric | Q4 2019dderived from reported figures | Q4 2018dderived from reported figures |
|---|---|---|
| Revenue | $6.52M | $4.94M |
| Net Income | -$20.92M | -$15.44M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Precision Biosciences Inc · CIK 1357874 · Engraved from SEC EDGAR
ended Dec 31, 2019 · filed Mar 10, 2020 · 70 d after period end
